The molecular basis of platelet biogenesis, activation, aggregation and implications in neurological disorders

References

• Ferrer-Acosta Y, González M, Fernández M, et al. Emerging roles for platelets in inflammation and disease. J Infect Disease Ther. 2014;2(4):149.
   PubMedGoogle Scholar
• Morita Y, Iseki A, Okamura S, et al. Functional characterization of hematopoietic stem cells in the spleen. Exp Hematol. 2011;39(3):351–359.
   PubMed Web of Science ®Google Scholar
• Thon JN, Italiano JE. Platelet formation. Semin Hematol. 2010;47(3):220–226.
   PubMed Web of Science ®Google Scholar
• Senis Y, García Á. Platelet proteomics: state of the art and future perspective. In: Jonathan MG, Martyn PM-Smith, editors. Platelets and megakaryocytes. New York (NY): Springer; 2012. p. 367–399.
   Google Scholar
• Bartley TD, Bogenberger J, Hunt P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI. Cell. 1994;77(7):1117–1124.
   PubMed Web of Science ®Google Scholar
• Hitchcock IS, Kaushansky K. Thrombopoietin from beginning to end. Br J Haematol. 2014;165(2):259–268.
   PubMed Web of Science ®Google Scholar
• Kim AR, Sankaran VG. Thrombopoietin: tickling the HSC’s fancy. EMBO Mol Med. 2018;10(1):10–12.
   PubMed Web of Science ®Google Scholar
• Choi ES, Nichol JL, Hokom MM, et al. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood. 1995;85(2):402–413.
   PubMed Web of Science ®Google Scholar
• Ito T, Ishida Y, Kashiwagi R, et al. Recombinant human c‐Mpl ligand is not a direct stimulator of proplatelet formation in mature human megakaryocytes. Br J Haematol. 1996;94(2):387–390.
   PubMed Web of Science ®Google Scholar
• Schulze H, Stegner D. Imaging platelet biogenesis in vivo. Res Pract Thromb Haemost. 2018;2(3):461–468.
   PubMed Web of Science ®Google Scholar
• Feese MD, Tamada T, Kato Y, et al. Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment. Proc Natl Acad Sci USA. 2004;101(7):1816–1821.
   PubMed Web of Science ®Google Scholar
• Ihle JN. Cytokine receptor signalling. Nature. 1995;377(6550):591–594.
   PubMed Web of Science ®Google Scholar
• Amigo JD, Ackermann GE, Cope JJ, et al. The role and regulation of friend of GATA-1 (FOG-1) during blood development in the zebrafish. Blood. 2009;114(21):4654–4663.
   PubMed Web of Science ®Google Scholar
• Tijssen MR, Cvejic A, Joshi A, et al. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell. 2011;20(5):597–609.
   PubMed Web of Science ®Google Scholar
• Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Investig. 2005;115(12):3339–3347.
   PubMed Web of Science ®Google Scholar
• Yang J, Ma J, Xiong Y, et al. Epigenetic regulation of megakaryocytic and erythroid differentiation by PHF2 histone demethylase. J Cell Physiol. 2018;233(9):6841–6852.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Komeno T, Suwabe N, et al. Role of GATA-1 in proliferation and differentiation of definitive erythroid and megakaryocytic cells in vivo. Blood. 1998;92(2):434–442.
   PubMed Web of Science ®Google Scholar
• Freson K, Wijgaerts A, Van Geet C. GATA1 gene variants associated with thrombocytopenia and anemia. Platelets. 2017;28(7):731–734.
   PubMed Web of Science ®Google Scholar
• Yu C, Niakan KK, Matsushita M, et al. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 2002;100(6):2040–2045.
   PubMed Web of Science ®Google Scholar
• Ciovacco WA, Raskind WH, Kacena MA. Human phenotypes associated with GATA-1 mutations. Gene. 2008;427(1–2):1–6.
   PubMed Web of Science ®Google Scholar
• Kim YW, Yun WJ, Kim A. Erythroid activator NF-E2, TAL1 and KLF1 play roles in forming the LCR HSs in the human adult β-globin locus. Int J Biochem Cell Biol. 2016;75:45–52.
   PubMed Web of Science ®Google Scholar
• Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development. Cell. 1995;81(5):695–704.
   PubMed Web of Science ®Google Scholar
• Gasiorek JJ, Blank V. Regulation and function of the NFE2 transcription factor in hematopoietic and non-hematopoietic cells. Cell Mol Life Sci. 2015;72(12):2323–2335.
   PubMed Web of Science ®Google Scholar
• Rost MS, Shestopalov I, Liu Y, et al. Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish. Blood Adv. 2018;2(23):3418–3427.
   PubMed Web of Science ®Google Scholar
• Lecine P, Villeval JL, Vyas P, et al. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood. 1998;92(5):1608–1616.
   PubMed Web of Science ®Google Scholar
• Lecine P, Blank V, Shivdasani R. Characterization of the hematopoietic transcription factor NF-E2 in primary murine megakaryocytes. J Biol Chem. 1998;273(13):7572–7578.
   PubMed Web of Science ®Google Scholar
• Levin J, Peng JP, Baker GR, et al. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2. Blood. 1999;94(9):3037–3047.
   PubMed Web of Science ®Google Scholar
• Lecine P, Italiano JE, Kim SW, et al. Hematopoietic-specific β1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2. Blood. 2000;96(4):1366–1373.
   PubMed Web of Science ®Google Scholar
• Tiwari S, Italiano JE, Barral DC, et al. A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood. 2003;102(12):3970–3979.
   PubMed Web of Science ®Google Scholar
• Nishimura S, Nagasaki M, Kunishima S, et al. IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol. 2015;209(3):453–466.
   PubMed Web of Science ®Google Scholar
• Machlus KR, Johnson KE, Kulenthirarajan R, et al. CCL5 derived from platelets increases megakaryocyte proplatelet formation. Blood. 2016;127(7):921–926.
   PubMed Web of Science ®Google Scholar
• tot Pannerden HV, de Haas F, Geerts W, et al. The platelet interior revisited: electron tomography reveals tubular α-granule subtypes. Blood. 2010;116(7):1147–1156.
   PubMed Web of Science ®Google Scholar
• Falet H. Anatomy of the platelet cytoskeleton In Paolo G, Neal SK, Jose AL, Clive PP, editors. Platelets in thrombotic and non-thrombotic disorders. Cham: Springer; 2017. p. 139–156.
   Google Scholar
• Venkatesh V, Kumar R, Varma DK, et al. Changes in platelet morphology indices in relation to duration of disease and glycemic control in children with type 1 diabetes mellitus. J Diabetes Complicat. 2018;32(9):833–838.
   PubMed Web of Science ®Google Scholar
• Rajagopal RL, Arunachalam S, Abdullah SM, et al. Can mean platelet volume and platelet distribution width be used as predictive markers for impending diabetic vascular complications? J Clin Diagn Res. 2018;12(2):EC01–EC05.
   Web of Science ®Google Scholar
• Beck F, Geiger J, Gambaryan S, et al. Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood. 2017;129(2):e1–2.
   PubMed Web of Science ®Google Scholar
• Pertseva N, Daria C, Igor T. Morphological changes of platelets as a marker of early progression of diabetic nephropathy. Diabetes. 2018;67(Suppl. 1). DOI:10.2337/db18-2194-PUB
   Google Scholar
• Sorrentino S, Studt JD, Horev MB, et al. Toward correlating structure and mechanics of platelets. Cell Adhesion Migr. 2016;10(5):568–575.
   PubMed Web of Science ®Google Scholar
• Moskalensky AE, Yurkin MA, Muliukov AR, et al. Method for the simulation of blood platelet shape and its evolution during activation. PLoS Comput Biol. 2018;14(3):e1005899.
   PubMed Web of Science ®Google Scholar
• Posch S, Neundlinger I, Leitner M, et al. Activation induced morphological changes and integrin αIIbβ3 activity of living platelets. Methods. 2013;60(2):179–185.
   PubMed Web of Science ®Google Scholar
• Bloom AL. Physiology of blood coagulation. Pathophysiol Haemos Thromb. 1990;20(1):14–29.
   Google Scholar
• John A, Gorzelanny C, Bauer AT, et al. Role of the coagulation system in genitourinary cancers. Clin Genitourin Cancer. 2018;16(1):e29–37.
   Web of Science ®Google Scholar
• Wong T. Dynamics of platelet shape change and aggregation in size-dependent platelet subpopulations [MSc thesis]. McGill University; 1988.
   Google Scholar
• Chandrashekar A, Singh G, Garry J, et al. Mechanical and biochemical role of fibrin within a venous thrombus. Eur J Vasc Endovasc Surg. 2018;55(3):417–424.
   PubMed Web of Science ®Google Scholar
• Hosseinzadegan H, Tafti DK. Mechanisms of platelet activation, adhesion, and aggregation. Thromb Haemost Res. 2017;1(2):1–6.
   Google Scholar
• Estevez B, Du X. New concepts and mechanisms of platelet activation signaling. Physiology. 2017;32(2):162–177.
   PubMed Web of Science ®Google Scholar
• Qiao J, Arthur JF, Gardiner EE, et al. Regulation of platelet activation and thrombus formation by reactive oxygen species. Redox Biol. 2018;14:126–130.
   PubMed Web of Science ®Google Scholar
• Roberts DE, McNicol A, Bose R. Mechanism of collagen activation in human platelets. J Biol Chem. 2004;279(19):19421–19430.
   PubMed Web of Science ®Google Scholar
• Brass LF, Newman DK, Wannemacher KM, et al. Signal transduction during platelet plug formation. Platelets. 2013;2:319–346.
   Google Scholar
• Nesbitt WS, Giuliano S, Kulkarni S, et al. Intercellular calcium communication regulates platelet aggregation and thrombus growth. J Cell Biol. 2003;160(7):1151–1161.
   PubMed Web of Science ®Google Scholar
• Durrant TN, van den Bosch MT, Hers I. Integrin αIIbβ3 outside-in signaling. Blood. 2017;130(14):1607–1619.
   PubMed Web of Science ®Google Scholar
• Seifert J, Rheinlaender J, Lang F, et al. Thrombin-induced cytoskeleton dynamics in spread human platelets observed with fast scanning ion conductance microscopy. Sci Rep. 2017;7(1):4810.
   PubMedGoogle Scholar
• Bennett JS. Platelet‐fibrinogen interactions. Ann N Y Acad Sci. 2006;936(1):340–354.
   Google Scholar
• Murugappa S, Kunapuli SP. The role of ADP receptors in platelet function. Front Biosci. 2006;11:1977–1986.
   PubMed Web of Science ®Google Scholar
• Jin J, Quinton TM, Zhang J, et al. Adenosine diphosphate (ADP)-induced thromboxane A2generation in human platelets requires coordinated signaling through integrin αIIbβ3 and ADP receptors. Blood. 2002;99(1):193–198.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Dopheide SM, Yap CL, et al. A revised model of platelet aggregation. J Clin Investig. 2000;105(6):783–791.
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC. Thrombus formation in vivo. J Clin Investig. 2005;115(12):3355–3362.
   PubMed Web of Science ®Google Scholar
• Clemetson KJ. Platelets and primary haemostasis. Thromb Res. 2012;129(3):220–224.
   PubMed Web of Science ®Google Scholar
• Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88(08):186–193.
   PubMedGoogle Scholar
• Panteleev MA, Dashkevich NM, Ataullakhanov FI. Hemostasis and thrombosis beyond biochemistry: roles of geometry, flow and diffusion. Thromb Res. 2015;136(4):699–711.
   PubMed Web of Science ®Google Scholar
• Paul BZ, Jin J, Kunapuli SP. Molecular mechanism of thromboxane A2-induced platelet aggregation: essential role for P2TAC and α2A receptors. J Biol Chem. 1999;274(41):29108–29114.
   PubMed Web of Science ®Google Scholar
• Perry V. Thromboxane A2 and TP receptors: a trail of research, well traveled. J S C Acad Sci. 2016;14(1):3.
   Google Scholar
• Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515.
   PubMedGoogle Scholar
• Kattula S, Byrnes JR, Wolberg AS. Fibrinogen and fibrin in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2017;37(3):e13–21.
   PubMed Web of Science ®Google Scholar
• Anthony M, Hinterberger H, Lance JW. Studies of serotonin metabolism in migraine. Proc Aust Assoc Neurol. 1968;5(1):109–112.
   PubMedGoogle Scholar
• Boullin DJ, Coleman M, O'Brien RA. Abnormalities in platelet 5-hydroxytryptamine efflux in patients with infantile autism. Nature. 1970;226(5243):371–372.
   PubMed Web of Science ®Google Scholar
• Adolfsson R, Gottfries CG, Oreland L, et al. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci. 1980;27(12):1029–1034.
   PubMed Web of Science ®Google Scholar
• Ehrlich D, Humpel C. Platelets in psychiatric disorders. World J Psychiatry. 2012;2(6):91.
   PubMedGoogle Scholar
• Kniewallner KM, Ehrlich D, Kiefer A, et al. Platelets in the Alzheimer’s disease brain: do they play a role in cerebral amyloid angiopathy? Curr Neurovasc Res. 2015;12(1):4–14.
   PubMed Web of Science ®Google Scholar
• Daly ME. Determinants of platelet count in humans. Haematologica. 2011;96(1):10–13.
   PubMed Web of Science ®Google Scholar
• del Zoppo GJ, von Kummer RÜ, Hamann GF. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry. 1998;65(1):1–9.
   PubMed Web of Science ®Google Scholar
• Marquardt L, Ruf A, Mansmann U, et al. Course of platelet activation markers after ischemic stroke. Stroke. 2002;33(11):2570–2574.
   PubMed Web of Science ®Google Scholar
• Bath P, Algert C, Chapman N, et al. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35(3):622–626.
   PubMed Web of Science ®Google Scholar
• Lai HM, Xu R, Yang YN, et al. Association of mean platelet volume with angiographic thrombus burden and short‐term mortality in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cathet Cardiovasc Intervent. 2015;85(S1):724–733.
   PubMedGoogle Scholar
• Du J, Wang Q, He B, et al. Association of mean platelet volume and platelet count with the development and prognosis of ischemic and hemorrhagic stroke. Int J Lab Hematol. 2016;38(3):233–239.
   PubMed Web of Science ®Google Scholar
• Maguire JM, Thakkinstian A, Sturm J, et al. Polymorphisms in platelet glycoprotein 1bα and factor VII and risk of ischemic stroke: a meta-analysis. Stroke. 2008;39(6):1710–1716.
   PubMed Web of Science ®Google Scholar
• Meisinger C, Prokisch H, Gieger C, et al. A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet. 2009;84(1):66–71.
   PubMed Web of Science ®Google Scholar
• Vasudeva K, Munshi A. Genetics of platelet traits in ischaemic stroke: focus on mean platelet volume and platelet count. Int J Neurosci. 2019;129(5):511–522.
   PubMed Web of Science ®Google Scholar
• Ghevaert C, Salsmann A, Watkins NA, et al. nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the αIIbβ3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia. Blood. 2008;111(7):3407–3414.
   PubMed Web of Science ®Google Scholar
• Bury L, Malara A, Gresele P, et al. Outside-in signalling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes. PLoS One. 2012;7(4):e34449.
   PubMed Web of Science ®Google Scholar
• Tohgi H, Suzuki H, Tamura K, et al. Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke. 1991;22(1):17–21.
   PubMed Web of Science ®Google Scholar
• O’Malley T, Langhorne P, Elton RA, et al. Platelet size in stroke patients. Stroke. 1995;26(6):995–999.
   PubMed Web of Science ®Google Scholar
• Butterworth RJ. The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets. 1998;9(6):359–364.
   PubMed Web of Science ®Google Scholar
• Yang M, Pan Y, Li Z, et al. Platelet count predicts adverse clinical outcomes after ischemic stroke or TIA: subgroup analysis of CNSR II. Front Neurol. 2019;10:370.
   PubMed Web of Science ®Google Scholar
• Brown AS, Martin JF. The megakaryocyte platelet system and vascular disease. Eur J Clin Investig. 1994;24(S1):9–15.
   PubMedGoogle Scholar
• Vyas P, McDevitt MA, Cantor AB, et al. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development. 1999;126(12):2799–2811.
   PubMed Web of Science ®Google Scholar
• Kunishima S, Kobayashi R, Itoh TJ, et al. Mutation of the β1-tubulin gene associated with congenital macrothrombocytopenia affecting microtubule assembly. Blood. 2009;113(2):458–461.
   PubMed Web of Science ®Google Scholar
• Rius-Pérez S, Tormos AM, Pérez S, et al. Vascular pathology: cause or effect in Alzheimer disease? Neurología (Engl. Ed.). 2018;33(2):112–120.
   PubMed Web of Science ®Google Scholar
• Catricala S, Torti M, Ricevuti G. Alzheimer disease and platelets: how’s that relevant. Immun Ageing. 2012;9(1):20.
   PubMed Web of Science ®Google Scholar
• Canobbio I, Visconte C, Momi S, et al. Platelet amyloid precursor protein is a modulator of venous thromboembolism in mice. Blood. 2017;130(4):527–536.
   PubMed Web of Science ®Google Scholar
• Padovani A, Pastorino L, Borroni B, et al. Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology. 2001;57(12):2243–2248.
   PubMed Web of Science ®Google Scholar
• Cupello A, Favale E, Audenino D, et al. Decrease of serotonin transporters in blood platelets after epileptic seizures. Neurochem Res. 2005;30(4):425–428.
   PubMed Web of Science ®Google Scholar
• Rainesalo S, Keränen T, Saransaari P, et al. GABA and glutamate transporters are expressed in human platelets. Mol Brain Res. 2005;141(2):161–165.
   PubMedGoogle Scholar
• Plagg B, Marksteiner J, Kniewallner KM, et al. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer’s disease mouse models and in human patients with Alzheimer’s disease. Biogerontology. 2015;16(4):543–558.
   PubMed Web of Science ®Google Scholar
• Ponomarev ED. Fresh evidence for platelets as neuronal and innate immune cells: their role in the activation, differentiation, and deactivation of Th1, Th17, and tregs during tissue inflammation. Front Immunol. 2018;9:406.
   PubMed Web of Science ®Google Scholar
• Tufekci KU, Meuwissen R, Genc S, et al. Inflammation in Parkinson’s disease. In Rossen D, editor. Advances in protein chemistry and structural biology. Vol. 88. 2012. United Kingdom (UK): Academic Press. p. 69–132.
   Google Scholar
• Koçer A, Yaman A, Niftaliyev E, et al. Assessment of platelet indices in patients with neurodegenerative diseases: mean platelet volume was increased in patients with Parkinson’s disease. Curr Gerontol Geriatr Res. 2013;2013:1–5.
   Google Scholar
• Tanik N, Milanlioglu A, Okyay MY, et al. The relationship between neuroinflammation, MPV and Parkinson’s disease. Eur Geriatr Med. 2013;6(4):418–419.
   Google Scholar
• Barnum CJ, Tansey MG. Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson’s disease? Curr Neurol Neurosci Rep. 2012;12(4):350–358.
   PubMed Web of Science ®Google Scholar
• Yazici S, Yazici M, Erer B, et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets. 2010;21(2):122–125.
   PubMed Web of Science ®Google Scholar
• Asor E, Ben-Shachar D. Platelets: a possible glance into brain biological processes in schizophrenia. World J Psychiatry. 2012;2(6):124.
   PubMedGoogle Scholar
• Osinga TE, van der Horst-Schrivers AN, van Faassen M, et al. Dopamine concentration in blood platelets is elevated in patients with head and neck paragangliomas. Clin Chem Lab Med. 2016;54(8):1395–1401.
   PubMed Web of Science ®Google Scholar
• Dietrich-Muszalska A, Olas B. The changes of aggregability of blood platelets in schizophrenia. World J Biol Psychiatry. 2009;10(2):171–176.
   PubMed Web of Science ®Google Scholar
• Dietrich-Muszalska A, Wachowicz B. Platelet haemostatic function in psychiatric disorders: effects of antidepressants and antipsychotic drugs. World J Biol Psychiatry. 2017;18(8):564–574.
   PubMed Web of Science ®Google Scholar
• Saluk-Bijak J, Dziedzic A, Bijak M. Pro-thrombotic activity of blood platelets in multiple sclerosis. Cells. 2019;8(2):110.
   PubMed Web of Science ®Google Scholar
• Plantone D, Inglese M, Salvetti M, et al. A perspective of coagulation dysfunction in multiple sclerosis and in experimental allergic encephalomyelitis. Front Neurol. 2018;9:1175.
   PubMed Web of Science ®Google Scholar
• Dukhinova MS, Ponomarev ED. Role of platelets in neuroinflammatory disorders. A review. Moscow Univ Biol Sci Bull. 2018;73(3):97–103.
   Google Scholar
• Steinman L. Platelets provide a bounty of potential targets for therapy in multiple sclerosis. Circ Res. 2012;110(9):1157–1158.
   PubMed Web of Science ®Google Scholar
• Sato D, Callegaro D, Lana-Peixoto MA, et al. Treatment of neuromyelitis optica: an evidence based review. Arq Neuro-Psiquiatr. 2012;70(1):59–66.
   PubMed Web of Science ®Google Scholar
• De Luca C, Colangelo AM, Alberghina L, et al. Neuro-immune hemostasis: homeostasis and diseases in the central nervous system. Front Cell Neurosci. 2018;12:459.
   PubMed Web of Science ®Google Scholar
• Bijak M, Olejnik A, Rokita B, et al. Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients. J Cell Mol Med. 2019;23(5):3476–3482.
   PubMed Web of Science ®Google Scholar